Epidemiology of covid-19 in patients on renal replacement therapy in the Russian federation in 2021 (brief report)
- Autores: Shilov E.M.1, Shilova M.M.2, Rumyantseva E.I.1, Yesayan A.M.3, Kotenko O.N.4
-
Afiliações:
- Sechenov University
- Pirogov Russian National Research Medical University
- Pavlov University
- Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology, Moscow City Clinical Hospital № 52
- Edição: Volume 14, Nº 2 (2022)
- Páginas: 6-8
- Seção: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/276072
- DOI: https://doi.org/10.18565/nephrology.2022.2.6-8
- ID: 276072
Citar
Texto integral



Resumo
Texto integral

Sobre autores
Evgeny Shilov
Sechenov UniversityDr. Sci. (Med.), Professor Moscow, Russia
Marina Shilova
Pirogov Russian National Research Medical UniversityAssociate Professor Moscow, Russia
Elizaveta Rumyantseva
Sechenov UniversityHigher School of Healthcare Management, Institute of Leadership and Healthcare Management Moscow, Russia
Ashot Yesayan
Pavlov UniversityDr. Sci. (Med.), Professor St. Petersburg, Russia
Oleg Kotenko
Moscow City Scientific and Practical Center for Nephrology and Transplanted Kidney Pathology, Moscow City Clinical Hospital № 52Cand. Sci. (Med.) Moscow, Russia
Bibliografia
- Шилов Е.М., Котенко О.Н., Шилова М.М., Мильчаков К.С., Румянцева Е.И., Хальфин Р.А. Эпидемиология COVID-19y больных, получающих заместительную почечную терапию в Российской Федерации: итоги 2020 г. Клиническая нефрология. 2021;1: 5-12.
- Котенко О.Н., Васина Н.В., Марченкова Л.В., Лысенко М.А. Состояние заместительной терапии хронической почечной недостаточности в Москве в 2015-2020 гг. Клиническая нефрология. 2021;1: 13-19.
Arquivos suplementares
